01—History
Depreciation & Amortization History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $211.0M
1 older move runs past ±150% (largest +648.4%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is depreciation & amortization?
Depreciation and amortization represents the non-cash expense of allocating the cost of tangible and intangible assets over their useful lives.
What is Moderna, Inc.'s current depreciation & amortization?
Moderna, Inc. (MRNA) annual depreciation & amortization for 2025 was $211.0M, a 14.05% increase from 2024. Moderna, Inc. depreciation & amortization for the quarter ending March 31, 2026 was $56.0M.
What was Moderna, Inc.'s depreciation & amortization in 2024?
Moderna, Inc. annual depreciation & amortization for 2024 was $185.0M, a 70.02% decline from 2023.
What was Moderna, Inc.'s depreciation & amortization in 2023?
Moderna, Inc. annual depreciation & amortization for 2023 was $617.0M, a 77.30% increase from 2022.
What is Moderna, Inc.'s 5-year depreciation & amortization CAGR?
Moderna, Inc. depreciation & amortization grew at a compound annual growth rate (CAGR) of 46.75% from FY2020 to FY2025, going from $31.0M to $211.0M over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)